Health Perspectives
We all want better healthcare, sooner and the potential is there to make it happen: New technology, new breakthroughs, new ideas. But while there are opportunities, there are challenges too: constrained budgets, an ageing population and an increase in chronic conditions. Find out what our specialists have to say on the issues that matter.
15 May 2019
By Shamil Ganatra and Hannah Cross. We have been working with a number of NHS trusts across the country supporting them to make the most of Model Hospital, the quality of its insight, ability to usefully compare to peers , and to improve their financial performance as a consequence. There are five things we think a trust needs to consider to make best use of this tool.
01 May 2019
By Sham Ganatra & Tom Usher. Making every pound count is a real challenge for all healthcare providers. Our experience has taught us that there are some key steps providers can take to better manage discretionary spend and, in doing so, improve short term financial performance.
11 April 2019
By Damien Ashford and Nancy Park. We share our thoughts and guidance on what commissioning organisations can do when faced with growing financial challenge.
08 April 2019
By Lucy Stapleton and Dr Luke Solon. Projections vary but the higher ones have estimated that a British medical marijuana market could be worth up to £8 billion a year. Although it appears to be winning political support, convincing some medical professionals to begin prescribing may be challenging without more definitive data.
04 April 2019
Our NHS NEDs programme chair Mike Farrar asked NHS Resolution CEO Helen Vernon for her insights into how they go about supporting NHS staff.
21 March 2019
By Karen Finlayson. How can NHS organisations improve the situation for their BAME employees who are not represented equally in the top jobs?
11 March 2019
By David Cockayne and Tom Mytton. Following the recent upturn in fortunes for Manchester United, after the surprise appointment of Ole Gunnar Solskjaer, we ask what lessons could be learned by organisations like the NHS, and organisational leadership?
27 February 2019
By James Macpherson & Jake Wilkins. Winter in an acute trust is always a difficult time. And North Bristol Trust (NBT) certainly wasn’t immune with bed occupancy regularly running at 102% last winter, and a four hour waiting time performance of 71%. So in Spring of 2018 they decided they something had to change if they were to avoid a repeat performance - or things getting worse...
21 February 2019
By Chris Spellman. Like the interpretation of A&E performance statistics, improving the current position is not straightforward.
18 February 2019
By Krishna Vallurupalli. Although AI is generating a huge buzz, pharma executives need to carefully consider its business implications.
13 February 2019
By David Cockayne and Dan Deacon. Through the Governance Dividend, system-wide efficiencies and coordinated place-based transformations are achievable, and, crucially, will support the objective of driving greater integration, delivering clear benefits for all the individual organisations involved and their communities.
12 February 2019
By Sam Kay, Consulting, Pharmaceutical and Life Sciences. A challenging road lies ahead for pharmaceutical firms and healthcare providers with the implementation of the EU Falsified Medicines Directive (FMD). But for agile players, this could also create a perfect opportunity to use new data to optimise their supply chains and improve patient interactions.
06 February 2019
With the word ‘crisis’ appearing regularly in newspaper headlines, it’s perhaps not surprising that some may be a little concerned about the state of the UK’s care workforce. It’s unarguably the case that the demands on the care sector are growing rapidly - and these are set to rise even higher.
04 February 2019
The NHS Long Term Plan provides a route map to sustainability - the key remains how to implement it whilst dealing with the day to day. The lessons shared in the new edition of 'Road to Recovery' are important for achieving financial sustainability.
04 February 2019
In today’s rapidly changing healthcare ecosystem, the importance of managing complexity cannot be overemphasised. The all-important Gross to Net (G2N) concept of drug pricing is squarely in the cross-hairs for pharmaceutical managers and is key to managing drug access and profitability.
31 January 2019
Last year the NHS celebrated its 70th birthday. Now, as it looks forward to the next decade, the NHS has published an ambitious plan that, if implemented effectively, means the organisation will look and operate very differently when it reaches its 80th anniversary.
29 January 2019
By Lucy Stapleton. As more digital therapeutics and connected devices come onto the market, pharmaceutical companies will have to change their approach to product discovery and development, focusing on solutions that have demonstrable outcomes for patients and providers.
14 January 2019
The current pressure on the NHS is immense and despite efforts, the day to day is constant firefighting. Step forward the new NHS 10 year plan.
14 December 2018
Winter in an NHS acute trust is often the year’s toughest period; with increased demand in the hospital and community causing immense pressure over the whole system. This blog identifies 4 key focus areas to help improve patient flow.
13 December 2018
A recent survey reported by the HSJ shows that the public’s highest priorities for new NHS funding are cancer care and staffing, while their lowest are digital access and better services for vulnerable groups. While it is understandable that the public would choose ‘clinical’ over ‘digital’ in a binary choice, we should be very clear in our viewpoint that , the two things are not mutually exclusive and that we need to be making the case for how digital will bring enormous benefits to patients, not just in terms of processes but also in terms of the quality of their own treatment and care.
